Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析

◆英語タイトル:Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1585
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Abbott Laboratories (ABT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott Laboratories (Abbott) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices, including electrophysiology, heart failure, rhythm management, vascular and structural heart devices, and neuromodulation devices. It has research and development facilities in the US, China, Colombia, India, Singapore, Spain, and the UK; and operates manufacturing facilities across the world. The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Apr 21,2020 Quest Diagnostics begins to perform COVID-19 Antibody Testing
Apr 16,2020 C-Hear Executive Dylan Rafaty reappointed as Vice-Chair to Committee On People with Disabilities by Texas Governor Greg Abbott
Apr 16,2020 Abbott reports first-quarter 2020 results
Feb 11,2020 Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Abbott Laboratories – Key Facts
Abbott Laboratories – Key Employees
Abbott Laboratories – Key Employee Biographies
Abbott Laboratories – Major Products and Services
Abbott Laboratories – History
Abbott Laboratories – Company Statement
Abbott Laboratories – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Abbott Laboratories – Business Description
Business Segment: Diagnostic Products
Overview
Performance
Key Stats
Business Segment: Established Pharmaceutical Products
Overview
Performance
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Nutritional Products
Overview
Performance
Key Stats
Business Segment: Others
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: India
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: United States
Performance
R&D Overview
Abbott Laboratories – SWOT Analysis
SWOT Analysis – Overview
Abbott Laboratories – Strengths
Abbott Laboratories – Weaknesses
Abbott Laboratories – Opportunities
Abbott Laboratories – Threats
Abbott Laboratories – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abbott Laboratories, Medical Equipment, Deals By Year, 2014 to YTD 2020
Abbott Laboratories, Medical Equipment, Deals By Type, 2014 to YTD 2020
Abbott Laboratories, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 21, 2020: Quest Diagnostics begins to perform COVID-19 Antibody Testing
Apr 16, 2020: C-Hear Executive Dylan Rafaty reappointed as Vice-Chair to Committee On People with Disabilities by Texas Governor Greg Abbott
Apr 16, 2020: Abbott reports first-quarter 2020 results
Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Nov 06, 2019: Abbott announces discovery of new strain of HIV, keeping global health community a step ahead of the virus
Oct 29, 2019: Abbott to build medical device manufacturing facility in Indiana
Oct 16, 2019: Abbott reports third-quarter 2019 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Abbott Laboratories, Key Facts
Abbott Laboratories, Key Employees
Abbott Laboratories, Key Employee Biographies
Abbott Laboratories, Major Products and Services
Abbott Laboratories, History
Abbott Laboratories, Other Locations
Abbott Laboratories, Subsidiaries
Abbott Laboratories, Business Unit
Abbott Laboratories, Key Competitors
Abbott Laboratories, Ratios based on current share price
Abbott Laboratories, Annual Ratios
Abbott Laboratories, Annual Ratios (Cont...1)
Abbott Laboratories, Annual Ratios (Cont...2)
Abbott Laboratories, Interim Ratios
Abbott Laboratories, Medical Equipment, Deals By Year, 2014 to YTD 2020
Abbott Laboratories, Medical Equipment, Deals By Type, 2014 to YTD 2020
Abbott Laboratories, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Abbott Laboratories, Performance Chart (2015 - 2019)
Abbott Laboratories, Ratio Charts
Abbott Laboratories, Medical Equipment, Deals By Year, 2014 to YTD 2020
Abbott Laboratories, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Abbott Laboratories (ABT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FHI 360:企業の戦略的SWOT分析
    FHI 360 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Bata India Limited:企業の戦略・SWOT・財務情報
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Saudi Kayan Petrochemical Co (2350):企業の財務・戦略的SWOT分析
    Summary Saudi Kayan Petrochemical Co (Saudi Kayan) is a petrochemical company that manufactures and markets specialty chemicals. The company offers products such as ethanolamines, ethoxylates, phenol, cumene, polycarbonate, ethylene, propylene, polyethylene, monoethanolamine, diethanolamine, trietha …
  • The Walsh Group:企業の戦略・SWOT・財務分析
    The Walsh Group - Strategy, SWOT and Corporate Finance Report Summary The Walsh Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • China Gezhouba Group Co Ltd (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cypress Energy Partners LP (CELP):石油・ガス:M&Aディール及び事業提携情報
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …
  • Centric Health Corp (CHH):製薬・医療:M&Aディール及び事業提携情報
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • DASAN ZHONE SOLUTIONS, INC.:企業の戦略・SWOT・財務情報
    DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report Summary DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Unilab (Philippines) Inc:企業の戦略的SWOT分析
    Unilab (Philippines) Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Marafiq:企業の発電所・SWOT分析2018
    Marafiq - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Laredo Petroleum Inc (LPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Laredo Petroleum Inc (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company h …
  • Odebrecht S.A.:戦略・SWOT・企業財務分析
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Pharm-Olam International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics subm …
  • LafargeHolcim Ltd.:企業のM&A・事業提携・投資動向
    LafargeHolcim Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LafargeHolcim Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • EOS imaging SA (EOSI):企業の財務・戦略的SWOT分析
    EOS imaging SA (EOSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Neenah Inc:企業の戦略・SWOT・財務情報
    Neenah Inc - Strategy, SWOT and Corporate Finance Report Summary Neenah Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • bitop AG-医療機器分野:企業M&A・提携分析
    Summary Bitop AG (bitop) is a developer, manufacturer and marketer of cosmetic ingredients. The company offers extremolytes, medical devices, cosmetic ingredients and bio-stabilizer products. It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applic …
  • China Bohai Bank Co., Ltd:企業の戦略・SWOT・財務情報
    China Bohai Bank Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary China Bohai Bank Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BW Offshore Ltd (BWO):石油・ガス:M&Aディール及び事業提携情報
    Summary BW Offshore Ltd (BW Offshore) is a floating production services provider to the oil and gas industry. The company specializes in the design, development, and operation of oil and gas Floating Production, Storage and Offloading (FPSO) and Floating, Storage and Offloading (FSO) vessels. It off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆